Hove Anders D
Director at Anacor Pharmaceuticals Inc
- Sold, on record
- $191M
- Dollars the filings state
- Form 4 sales
- 12
- Latest May 16, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Anacor Pharmaceuticals IncDirector
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Anacor Pharmaceuticals IncPlan not statedSep 16 2014
Sold 90,000 shares at $24.99 ($2.2M)
Hove Anders D, Director
Sold 2.5% of holdings ($89.3M position)3.5M shares left2.6x usual sizeFiling
- 2 Form 4 sale Anacor Pharmaceuticals IncUnusualSep 19 +3 days
Sold 740,000 shares at $24.87 ($18.4M)
Hove Anders D, Director
Sold 21.2% of holdings ($86.7M position)2.7M shares left8.2x usual sizeFiling
- 3 Form 4 sale Anacor Pharmaceuticals IncPlan not statedSep 26 +7 days
Sold 20,000 shares at $25.00 ($500k)
Hove Anders D, Director
Sold 0.7% of holdings ($68.6M position)2.7M shares left0.1x usual sizeFiling
- 4 Form 4 sale Anacor Pharmaceuticals IncPlan not statedNov 10 +410 days
Sold 100,295 shares at $103.60 ($10.4M)
Hove Anders D, Director
Sold 5.9% of holdings ($176M position)1.6M shares left0.8x usual sizeFiling
- 5 Form 4 sale Anacor Pharmaceuticals IncUnusualDec 11 +31 days
Sold 40,000 shares at $117.36 ($4.7M)
Hove Anders D, Director
Sold 54.1% of holdings ($8.7M position)33,886 shares left0.4x usual sizeFiling
- 6 Form 4 sale Anacor Pharmaceuticals IncUnusualDec 15 +4 days
Sold 900,000 shares at $111.25 ($100M)
Hove Anders D, Director
Sold 73.4% of holdings ($136M position)325,535 shares left10x usual sizeFiling
- 7 Form 4 sale Anacor Pharmaceuticals IncUnusualApr 8 +115 days
Sold 229,301 shares at $71.10 ($16.3M)
Hove Anders D, Director
Sold 70.4% of holdings ($23.1M position)96,234 shares left2.4x usual sizeFiling
- 8 Form 4 sale Anacor Pharmaceuticals IncUnusualMay 16 +38 days
Sold 353,881 shares at $99.59 ($35.2M)
Hove Anders D, Director
Sold 100% of holdings ($35.2M position)0 shares left3.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 16, 2016 | Anacor Pharmaceuticals Inc | Director | Form 4 sale | 353,881 | $35.2M | 100.0% | Unusual | SEC |
| Apr 8, 2016 | Anacor Pharmaceuticals Inc | Director | Form 4 sale | 229,301 | $16.3M | 70.4% | Unusual | SEC |
| Dec 15, 2015 | Anacor Pharmaceuticals Inc | Director | Form 4 sale | 900,000 | $100M | 73.4% | Unusual | SEC |
| Dec 11, 2015 | Anacor Pharmaceuticals Inc | Director | Form 4 sale | 40,000 | $4.7M | 54.1% | Unusual | SEC |
| Nov 10, 2015 | Anacor Pharmaceuticals Inc | Director | Form 4 sale | 100,295 | $10.4M | 5.9% | Plan not stated | SEC |
| Sep 26, 2014 | Anacor Pharmaceuticals Inc | Director | Form 4 sale | 20,000 | $500k | 0.7% | Plan not stated | SEC |
| Sep 19, 2014 | Anacor Pharmaceuticals Inc | Director | Form 4 sale | 740,000 | $18.4M | 21.2% | Unusual | SEC |
| Sep 16, 2014 | Anacor Pharmaceuticals Inc | Director | Form 4 sale | 90,000 | $2.2M | 2.5% | Plan not stated | SEC |
| Nov 15, 2013 | Anacor Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 150,000 | $2.1M | 4.0% | Unusual | SEC |
| Sep 20, 2012 | Anacor Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 19,273 | $121k | 0.5% | Plan not stated | SEC |
| Sep 14, 2012 | Anacor Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 35,000 | $228k | 0.9% | Plan not stated | SEC |
| Sep 13, 2012 | Anacor Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 25,177 | $166k | 0.7% | Plan not stated | SEC |